Pages that link to "Q43151578"
Jump to navigation
Jump to search
The following pages link to Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model (Q43151578):
Displaying 46 items.
- Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina (Q21260371) (← links)
- Amyloidosis in Retinal Neurodegenerative Diseases (Q26739839) (← links)
- Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and Progression (Q26752621) (← links)
- Update on Clinical Trials in Dry Age-related Macular Degeneration (Q26767098) (← links)
- The proteomics of drusen (Q26997523) (← links)
- At the interface of sensory and motor dysfunctions and Alzheimer's disease (Q27000410) (← links)
- Beta-Amyloid Precursor Protein (βAPP) Processing in Alzheimer's Disease (AD) and Age-Related Macular Degeneration (AMD) (Q27021938) (← links)
- Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in age-related macular degeneration mouse model (Q27316689) (← links)
- Recent developments in the management of dry age-related macular degeneration (Q28088816) (← links)
- Human retinal transmitochondrial cybrids with J or H mtDNA haplogroups respond differently to ultraviolet radiation: implications for retinal diseases (Q28539574) (← links)
- Mitochondrial disorders and the eye. (Q33702120) (← links)
- The complexities underlying age-related macular degeneration: could amyloid beta play an important role? (Q33702571) (← links)
- Soluble and mature amyloid fibrils in drusen deposits (Q33735695) (← links)
- A retinal proteomics-based study identifies αA-crystallin as a sex steroid-regulated protein. (Q33825549) (← links)
- Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease (Q34277495) (← links)
- Iron increases APP translation and amyloid-beta production in the retina (Q34656959) (← links)
- Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. (Q35105102) (← links)
- SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease (Q35639816) (← links)
- Cyclic intensive light exposure induces retinal lesions similar to age-related macular degeneration in APPswe/PS1 bigenic mice (Q35917824) (← links)
- Lower cognitive function in patients with age-related macular degeneration: a meta-analysis (Q35953525) (← links)
- Differential accumulation of secreted AbetaPP metabolites in ocular fluids (Q36097397) (← links)
- Brain-derived neurotrophic factor in patients with advanced age-related macular degeneration (Q36243076) (← links)
- Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration (Q36311846) (← links)
- Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin (Q36319298) (← links)
- Immune-directed gene therapeutic development for Alzheimer's, prion, and Parkinson's diseases (Q37302816) (← links)
- Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging (Q37395303) (← links)
- Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina? (Q37874157) (← links)
- Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures (Q37879172) (← links)
- Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment (Q37985523) (← links)
- Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma (Q38018840) (← links)
- The retina as a window to the brain-from eye research to CNS disorders (Q38061012) (← links)
- Advances in the management of macular degeneration (Q38214725) (← links)
- Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways (Q38381041) (← links)
- Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease (Q39091275) (← links)
- Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease (Q42002890) (← links)
- Expression of human complement factor H prevents age-related macular degeneration-like retina damage and kidney abnormalities in aged Cfh knockout mice (Q43083299) (← links)
- Current drug and molecular therapies for the treatment of atrophic age-related macular degeneration: phase I to phase III clinical development (Q45870879) (← links)
- Vitamin D and Age-Related Macular Degeneration (Q47100212) (← links)
- Understanding AMD by analogy: systematic review of lipid-related common pathogenic mechanisms in AMD, AD, AS and GN. (Q47751388) (← links)
- Maternal imprinting on cognition markers of wild type and transgenic Alzheimer's disease model mice. (Q52565458) (← links)
- The amplification loop of the complement pathways. (Q52704996) (← links)
- Thermal Stimulation of the Retina Reduces Bruch's Membrane Thickness in Age Related Macular Degeneration Mouse Models. (Q55016413) (← links)
- Investigating Multimodal Diagnostic Eye Biomarkers of Cognitive Impairment by Measuring Vascular and Neurogenic Changes in the Retina (Q60046132) (← links)
- Amyloid β Induces Early Changes in the Ribosomal Machinery, Cytoskeletal Organization and Oxidative Phosphorylation in Retinal Photoreceptor Cells (Q64110774) (← links)
- Smoking mice: a potential model for studying accumulation of drusen-like material on Bruch's membrane (Q84573245) (← links)
- Plasma levels of amyloid beta and other proinflammatory mediators in patients with age-related macular degeneration (Q86876467) (← links)